Tyrosine kinase inhibitor treatment outcome in a single center cohort of chronic myeloid leukemia patients. The role of the T315I ABL kinase domain mutation

by Dima Delia, Trifa Adrian P., Paţiu Mariana, Vesa Cristian S., Frinc Ioana C., Petrov Ljubomir, Cucuianu Andrei
Published 2013-03-01